AC
TMO icon

Alexandria Capital’s Thermo Fisher Scientific TMO Stock Holding History

Alexandria Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$11.5M Sell
20,137
-244
-1% -$134K 1.07% 18
2021
Q2 		$10.3M Sell
20,381
-217
-1% -$102K 0.95% 28
2021
Q1 		$9.4M Sell
20,598
-162
-0.8% -$77.3K 0.95% 25
2020
Q4 		$9.67M Sell
20,760
-85
-0.4% -$39.9K 1.02% 20
2020
Q3 		$9.2M Sell
20,845
-1,536
-7% -$635K 1.1% 19
2020
Q2 		$8.11M Sell
22,381
-5,083
-19% -$1.7M 1.05% 25
2020
Q1 		$7.79M Sell
27,464
-278
-1% -$87.7K 1.27% 19
2019
Q4 		$9.01M Sell
27,742
-560
-2% -$170K 1.21% 22
2019
Q3 		$8.24M Sell
28,302
-683
-2% -$196K 1.22% 21
2019
Q2 		$8.51M Sell
28,985
-7,196
-20% -$1.98M 1.21% 20
2019
Q1 		$9.9M Sell
36,181
-2,037
-5% -$507K 1.44% 12
2018
Q4 		$8.55M Sell
38,218
-3,445
-8% -$808K 1.39% 16
2018
Q3 		$10.2M Sell
41,663
-185
-0.4% -$42.6K 1.5% 12
2018
Q2 		$8.67M Buy
41,848
+35
+0.1% +$7.43K 1.3% 17
2018
Q1 		$8.63M Sell
41,813
-1,205
-3% -$253K 1.28% 20
2017
Q4 		$8.17M Buy
43,018
+358
+0.8% +$68.6K 1.19% 20
2017
Q3 		$8.07M Sell
42,660
-1,600
-4% -$290K 2.03% 13
2017
Q2 		$7.72M Sell
44,260
-30
-0.1% -$5.04K 1.96% 13
2017
Q1 		$6.8M Sell
44,290
-1,420
-3% -$217K 1.7% 17
2016
Q4 		$6.45M Sell
45,710
-51,125
-53% -$7.54M 1.65% 17
2016
Q3 		$15.4M Sell
96,835
-6,930
-7% -$1.07M 2.83% 5
2016
Q2 		$15.3M Sell
103,765
-4,980
-5% -$735K 2.73% 5
2016
Q1 		$15.4M Buy
108,745
+61,469
+130% +$8.24M 2.76% 4
2015
Q4 		$6.71M Sell
47,276
-6,175
-12% -$824K 1.69% 16
2015
Q3 		$6.54M Sell
53,451
-400
-0.7% -$52.1K 1.59% 19
2015
Q2 		$7.36M Buy
+53,851
New +$7.02M 1.63% 17

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alexandria Capital's TMO Position: Q3 2021 in Review

Alexandria Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q3 2021, selling an estimated $134K and leaving 20,137 shares worth $11.5M. The position accounts for 1.07% of the portfolio, ranked #18.

Alexandria Capital first reported a position in TMO in Q2 2015 and has held it in 26 quarters since. The position peaked at $15.4M in Q3 2016. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Alexandria Capital held 20,137 shares of Thermo Fisher Scientific worth $11.5M as of Q3 2021.
  • Alexandria Capital sold 244 Thermo Fisher Scientific shares in Q3 2021, an estimated $134K.
  • Thermo Fisher Scientific made up 1.07% of Alexandria Capital's portfolio in Q3 2021, its #18 holding.
  • Alexandria Capital first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 26 quarters since.
  • Alexandria Capital's Thermo Fisher Scientific position peaked at $15.4M in Q3 2016.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.